BioNTech SE American Depositary Share Earnings Dividend

BioNTech SE American Depositary Share’s revenue fell -34.33% since last year same period to $120.04Mn in the Q1 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -86.65% fall in its revenue since last 3-months.

BioNTech SE American Depositary Share’s net profit fell -30.03% since last year same period to $-540.65Mn in the Q1 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -78.94% fall in its net profits since last 3-months.

BioNTech SE American Depositary Share’s net profit margin fell -98% since last year same period to -450.38% in the Q1 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -1239.92% fall in its net profit margins since last 3-months.

BioNTech SE American Depositary Share’s earning per share (EPS) estimates for the current quarter stand at -2.03 - a -721.2% fall from last quarter’s estimates.

BioNTech SE American Depositary Share’s earning per share (EPS) estimates for the current year stand at -2.03.

BioNTech SE American Depositary Share’s earning per share (EPS) fell -7.1% since last year same period to -1.95 in the Q1 2026. This indicates that the BioNTech SE American Depositary Share has generated -7.1% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. BioNTech SE American Depositary Share’s return on assets (ROA) stands at -0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. BioNTech SE American Depositary Share’s return on equity (ROE) stands at -0.07.